Ethical debate of use of healthy children as volunteers in clinicalPharmacokinetics

Abstract

CLC Number:

R96
R969.1

LI Jian-Chun, ZHENG Qing-Shan, SUN Rui-Yuan. Ethical debate of use of healthy children as volunteers in clinicalPharmacokinetics[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(4): 473-476.

References

1 Haslam RHA.Research in children— issues of risk and harm[A].In:Koren G,ed.Textbook of ethics inPediatric research[M].Malabar(FL):Kreiger,1993:25-36
2 Ondrusek N,Abramovitch R,PenharzP,et al.Empirical examinations of the ability of children to consent to clinical research[J].J Med Ethics,1998;24:158-65
3 Dept of Health and Human Services(US).Final Regulation Amending Basic HHSPolicy forProtection of Human Research Subjects[S].Federal Register,1981;46:8366-88
4 Medical Research Council,the Natural Sciences and Engineering Research Council,and the Social Sciences and Humanities Research Council.Tri-CouncilPolicy Statement:Ethical Conduct for Research Involving Humans.Natural Sciences and Engineering Research Council of Canada[EB OL].Available at:http:www.NSERC.ca
5 Freedman B.A moral theory of informed consent[J].Hastings Center Rep,1979;5:32-9
6 Humphrey GB,Boon CM,vanlinden van den Heuvell GF,et al.The occurrence of highlevels of acute behavioral distress in children and adolescents undergoing routine venipuncture[J].Pediatrics,1992;90:87-91
7 Kearns GL.Impact of developmentalPharmacology onPediatric study design:overcoming the challenges[J].J Allergy Clin Immunol,2000;106(Suppl 3):S128-38
8 Blanchette WS,Zipinsky A.Assessment of anemia in newborn infants[J].ClinPerinatol,1984;1:489-510
9 Koren G.Use of EMLA in young children forProcedure-relatedPain[J].JPediatr,1993;122:S30-5
10 Chesney RW,AdamsonP,Wells T,et al.The testing of antihypertensive medications in children:Report of the antihyper-tensive agent guidelines subcommittee of thePediatricPharmacology research units[J].Pediatrics,2001;107:558-61
11 Bishai R,Taddio A,Bar-Oz B,et al.Relative efficacy of amethocaine gel andlidocaine-prilocaine cream forPort-a-CathPuncture in children[J].Pediatrics,104;e31
12 Johnson KM,ColburnP,Sudson S,et al.Children in research speak for themselves [abstract] [J].ClinPharmacol Ther,1999;65:176
13 Gaylin W.Competence:nolonger all or none[A].In:Gaylin W,Macklin R,eds.Who speaks for the child[M].New York:PlenumPress,1982:27-54
14 Kearns GL.ThePediatricPharmacology research unit network:proof of concept[J].PaediatrPerinat Drug Ther,1999;1:9-14
15 卜擎燕,熊宁宁,吴静.人体生物医学研究国际道德指南[J].中国临床药理学与治疗学,2003;8:107-10
16 卜擎燕,熊宁宁,吴静.临床试验中特殊受试人群选择的国际伦理要求[J].中国临床药理学与治疗学,2003;8:356-60
17 翁维良,主编.中药临床药理学[M].第1版.北京:人民卫生出版社,2002:1012-20

[1]	WU Yujie, ZHAO Chengcheng, XI Qing. Evaluation of tegacycline regimens in treatment of gram-negative bacterial infections with Monte Carlo simulation [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1027-1033.
[2]	LI Kun, LI Lulu, LI Nannan, HU Weihong, ZHOU Jianchao. Effects of glycaemic control and CYP3A5 polymorphisms on tacrolimus trough concentrations after adult kidney transplantation [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 767-774.
[3]	HE Xueru, LI Ying, MA Yinling, FU Yuhao, XUN Xuejiao, DONG Zhanjun. Pharmacokinetic interaction study between sorafenib and dapagliflozin in rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 498-507.
[4]	HUANG Zhiwei, LI Yi, XU Xiaoyong, ZHANG Lei, SHEN Yifeng, LI Huafang. Comparison of calculation results of five population pharmacokinetic analysis tools [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 525-535.
[5]	LI Mengxue, HE Jie, YU Xiaxia, HU Linlin, SHAO Hua. Research progress in population pharmacokinetics of rituximab [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 468-474.
[6]	YAN Qiangyong, XIANG Daxiong, ZHU Ronghua, YANG Lingfeng, YANG Xiding, LI Jingjing, FAN Xiao, LIU Sai, XIONG Shoujun, FANG Pingfei. Bioequivalence study of cinacalcet hydrochloride tablets in healthy Chinese volunteers [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 171-177.
[7]	WANG Zhi, ZHOU Xin, HE Xueru, FU Yuhao, XUN Xuejiao, LI Ying, DONG Zhanjun. Clinical research progress of palbociclib in treatment of breast cancer [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 205-213.
[8]	LIU Lu, SHI Yufei, HE Qingfeng, XU Fengyan, WANG Kun, CAI Weimin, XIANG Xiaoqiang. Application of population modeling analysis to evaluate the impact of gene polymorphism on drug PK/PD [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1275-1282.
[9]	ZHOU Jiating, ZHANG Xuan, XIE Zilan, LI Zhi. Interactions and clinical significance of gut microbiota and levothyroxine [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1307-1314.
[10]	LI Xuejing, JIANG Jinping, LI Sining, WAN Linfei, ZHOU Xiangxiang, YANG Lian, LAN Ke. A bioequivalence study of generic and brand clozapine in schizophrenic patients [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1121-1130.
[11]	WU Lili, LIANG Zhi, HUANG Siyong, WANG Yan. Effect of augmented renal clearance (ARC) on the pharmacokinetics, efficacy, and safety of vancomycin in patients with infective endocarditis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1139-1145.
[12]	DAI Jiahui, SUN Sijia, XIE Xuefeng. Quality management and indicator system for clinical trials of medical devices [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 51-58.
[13]	MA Shen, LIU Yushuo, TANG Hui, CHEN Wenbin, GAO Ling. Pharmacokinetics and clinical significance of drugs for improving nonalcoholic fatty liver disease [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 908-918.
[14]	CHEN Jianfang, LOU Donghua. Design of case report form for oncology clinical trials based on CDASH [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 762-767.
[15]	DAI Jingyi, WANG Jingjing, ZHANG Jing, YU Jicheng, LI Nanyang, HUANG Zhiwei. Clinical application and research progress of inhaled methoxyflurane [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 808-813.